Captrust Financial Advisors Ani Pharmaceuticals Inc Transaction History

Captrust Financial Advisors

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$50.28 - $64.61 $3,016 - $3,876	60 Added 0.76%	7,904 $458,000
Q2 2023 Aug 14, 2023	BUY	$37.29 - $53.83 $292,502 - $422,242	7,844 New	7,844 $422,000
Q2 2022 Aug 16, 2022	BUY	$23.09 - $33.46 $2,493 - $3,613	108 Added 20.3%	640 $19,000
Q1 2022 May 16, 2022	BUY	$26.91 - $47.15 $12,566 - $22,019	467 Added 718.46%	532 $15,000
Q4 2021 Feb 14, 2022	BUY	$32.97 - $56.85 $560 - $966	17 Added 35.42%	65 $3,000
Q3 2021 Nov 16, 2021	BUY	$26.48 - $35.99 $503 - $683	19 Added 65.52%	48 $2,000
Q2 2021 Aug 16, 2021	SELL	$31.86 - $38.6 $637 - $772	-20 Reduced 40.82%	29 $1,000
Q1 2021 May 17, 2021	BUY	$28.4 - $36.14 $823 - $1,048	29 Added 145.0%	49 $2,000
Q4 2020 Feb 16, 2021	BUY	$23.69 - $31.47 $71 - $94	3 Added 17.65%	20 $1,000
Q2 2020 Aug 14, 2020	BUY	$29.93 - $50.1 $508 - $851	17 New	17 $1,000
Q4 2019 Feb 14, 2020	SELL	$55.65 - $79.83 $946 - $1,357	-17 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$45.83 - $70.54 $779 - $1,199	17 New	17 $1,000

211

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $986M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.